ABU DHABI, 10th March, 2025 (WAM) -- Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic Progenitor Cell Collection.
Prof Yendry Ventura, Chief Executive Officer of ADSCC and Adjunct Professor at United Arab Emirates University, said, “Achieving AABB accreditation marks a significant milestone in our commitment to excellence in cellular therapies. As the first institution in the UAE to receive this prestigious accreditation, we continue to set new benchmarks in quality and patient safety which is backed by a solid infrastructure, a state-of-the-art apheresis and ECP unit, and unparalleled clinical expertise.
This achievement underscores our dedication to pioneering cutting-edge treatments, enhancing healthcare standards, and reinforcing UAE’s position as a regional leader in regenerative medicine and biological sciences.”
Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic operated by ADSCC, said, “This achievement reflects the efforts and expertise of our entire team of scientists, haematologists, immunologists, nurses and technicians and beyond.
Being one of only two AABB-accredited facilities in the MENA region for HPC collection is a significant milestone for our patients and also physicians, and we are proud to contribute to the advancement of cellular therapy in the UAE and beyond.”
AABB’s accreditation programme is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field. AABB’s accreditation programme promotes the highest standards of care for patients, donors, processes and products in all aspects of transfusion medicine, biotherapies and relationship testing.